How to Structure MDR Technical Documentation (Annex II & III). A Practical Compliance Guide

REPHINE SPEECH MARKS OPEN MEDICALDEVICES

Is your organisation fully prepared to structure MDR Technical Documentation under Annex II and Annex III?
REPHINE SPEECH MARKS CLOSE MEDICALDEVICES

About this Whitepaper

This guide translates the legal language of Annex II and Annex III into a practical, reviewer friendly structure that supports faster assessment by Notified Bodies. It explains how to present device information, design and manufacturing evidence, GSPR demonstrations, verification and validation data, clinical evaluation and PMS outputs in a coherent and logically connected way.
 
The document emphasises the MDR requirement for Technical Documentation to be clear, organised, readily searchable and unambiguous. It also highlights the most frequent causes of review delays including incomplete submissions, inconsistent terminology and dossiers that require reviewers to search for links between claims and evidence.
Through best practice recommendations and explanations of common Notified Body observations, the white paper guides manufacturers to create documentation that supports lifecycle consistency and reduces question cycles.

What’s changing?

Organisations must adapt to MDR review patterns in which Notified Bodies do not read dossiers linearly. Instead, they move quickly between intended purpose, classification, GSPR mapping, risk management, verification and validation, clinical evidence and PMS. To meet expectations, manufacturers need Technical Documentation that demonstrates:

  • Clean device definition including intended purpose, variants, accessories and Basic UDI DI scope
  • Complete and cohesive information supplied with the device including labels, IFU and promotional materials
  • Clear design and manufacturing information with traceable links between design inputs, outputs, risk controls and verification evidence
  • Robust GSPR mapping with precise evidence references and justification for applicability or non applicability
  • Risk management aligned with ISO 14971 and integrated with verification, validation, clinical evaluation, usability and PMS
  • Verification and validation evidence that is complete, traceable and supported by accredited laboratories
  • PMS systems that operate as lifecycle feedback mechanisms and drive updates to risk, clinical evidence and documentation
  • SSCP requirements for implantable and class III devices where transparency and alignment with clinical and PMS outputs are essential
These elements reflect Notified Body expectations for documentation that is consistent, traceable and supported by justifiable regulatory reasoning.

Why it matters for your business

Well structured MDR Technical Documentation directly influences review timelines, inspection performance and market access. Poor organisation or inconsistent evidence presentation typically leads to additional reviewer rounds and delayed CE marking.
 
Manufacturers must therefore:
  • Map all device information and evidence to a coherent MDR aligned structure
  • Maintain terminology consistency across all documents including CER, RMF, IFU and PMS
  • Demonstrate clear requirement to evidence traceability with updated GSPR matrices and verification and validation summaries
  • Strengthen design and risk management integration through complete traceability between user needs, design inputs, hazards, risk controls and testing
  • Ensure PMS outputs genuinely inform lifecycle safety and performance decisions and align with clinical and risk files
A mature dossier signals system control, regulatory readiness and a high degree of organisational quality. It supports operational efficiency and positions the business for smoother regulatory pathways.

Take action now

With the MDR in full effect and Notified Bodies operating under heavy demand, documentation quality has never been more important. Organisations that invest early in structuring, updating and maintaining their Technical Documentation will minimise delays, reduce review friction and build a more resilient compliance framework.
 
This white paper provides practical recommendations, traceability models, architecture templates and insights into common review pitfalls, helping manufacturers create a sustainable documentation system that remains compliant throughout the device lifecycle.
 

👉 Download the full white paper below to discover how to structure MDR Technical Documentation in a clear, reliable and reviewer ready way.

Download the White Paper below

 

MockUp Resource Hub Web

View our other resources and company news

GMP Raising the bar Blog series Header image May 25 Article

Effective QMS Management Post-Go-Live: Strategies for Governance, Releases, and Continuous Improvement

After QMS go live, compliance and performance depend on strong governance, structured release management and continuous improvement. Learn how to sustain control, adoption and long ...
Read More
Ensuring Compliance and Data Integrity in Pharmacovigilan Case Study

GMP Consultancy for a New Manufacturing Plant

With only a small team and a highly automated process, this biotech company needed to achieve EU GMP compliance fast. This case study shows how ...
Read More
ICH E6 Guide Header Image (1500 x 844 px) Article

Why Quality Can No Longer Live in Silos

Discover why siloed quality management is no longer sustainable in life sciences. Learn how integrating audits, advisory services and digital quality systems supports continuous GxP ...
Read More
QMS IMP Header image Blog case study May 25 Article

Why Most QMS Implementations Fail to Deliver Long-Term Value

Implementing a QMS is more than deploying software. Learn why most QMS implementations fall short, and what successful life sciences teams do differently to achieve ...
Read More
Ensuring Compliance and Data Integrity in Pharmacovigilan Case Study

Driving Global QMS Harmonisation for a Pharmaceutical Company

This case study outlines how Rephine helped a global pharmaceutical group implement and validate a harmonised Quality Management System across more than seventy sites. It ...
Read More
CSV Blog

IT Quality Assurance in Regulated Life Sciences: Key Insights

IT Quality Assurance is pivotal in regulated life sciences. From CSV and data integrity to change control and audit readiness, discover how IT QA ensures ...
Read More
Ensuring Compliance and Data Integrity in Pharmacovigilan General

Practical compliance and inspection readiness for UK pharmaceutical quality systems

Explore how UK pharmaceutical and biotech organisations can stay prepared for MHRA, EMA and FDA inspections. This session provides expert guidance on inspection trends, compliance ...
Read More
BANNER Practical Guide to Post Market Surveillance PMS under EU MDR IVDR CSV

Practical Guide to the EMA’s Draft EU GMP Revisions

The EU’s new Product Liability Directive (2024/2853) changes who can be held liable and what damages can be claimed. From software and data loss to ...
Read More
BANNER Practical Guide to Post Market Surveillance PMS under EU MDR IVDR Guide

Practical Guide to Post-Market Surveillance (PMS) under EU MDR/IVDR

The EU’s new Product Liability Directive (2024/2853) changes who can be held liable and what damages can be claimed. From software and data loss to ...
Read More
Contact Us

Strengthen Your Assurance Journey

GMP Chapter 22 Adapting to Hybrid Documentation Standards